Related references
Note: Only part of the references are listed.Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy
Rong Fan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B
Margarita Papatheodoridi et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
Ivana Carey et al.
HEPATOLOGY (2020)
The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B
Grace L. -H. Wong et al.
LIVER INTERNATIONAL (2020)
Reverse transcriptase droplet digital PCR vs reverse transcriptase quantitative real-time PCR for serum HBV RNA quantification
Umaporn Limothai et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Can we stop nucleoside analogues before HBsAg loss?
Margarita Papatheodoridi et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
Umaporn Limothai et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
Yao-Chun Hsu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection
Shi Liu et al.
HEPATOLOGY (2019)
The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogues Cessation Among Asian Patients With Chronic Hepatitis B: A Systematic Review
Jiaye Liu et al.
HEPATOLOGY (2019)
Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA
En-Qiang Chen et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
Wen-Juei Jeng et al.
HEPATOLOGY (2018)
Chronic Hepatitis B Infection A Review
Lydia S. Y. Tang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B
Florian van Boemmel et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Stopping long-term treatment with nucleos(t)ide analogues is a favourable option for selected patients with HBeAg-negative chronic hepatitis B
Florian van Boemmel et al.
LIVER INTERNATIONAL (2018)
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection
L. -Y. Mak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study
Thomas Berg et al.
JOURNAL OF HEPATOLOGY (2017)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
Anna S. F. Lok et al.
HEPATOLOGY (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Discontinuation of oral antivirals in chronic hepatitis B: A systematic review
George Papatheodoridis et al.
HEPATOLOGY (2016)
Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2016)
Clinical relevance of the study of hepatitis B virus covalently closed circular DNA
Rajneesh Kumar et al.
LIVER INTERNATIONAL (2016)
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Michael Nassal
GUT (2015)
Serum Hepatitis B Virus RNA Levels as an Early Predictor of Hepatitis B Envelope Antigen Seroconversion During Treatment With Polymerase Inhibitors
Florian van Boemmel et al.
HEPATOLOGY (2015)
Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B
Sadahisa Okuhara et al.
HEPATOLOGY RESEARCH (2014)
Kinetics of Intrahepatic Covalently Closed Circular DNA and Serum Hepatitis B Surface Antigen During Antiviral Therapy for Chronic Hepatitis B: Lessons From Experimental and Clinical Studies
Fabien Zoulim et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
Akihiro Matsumoto et al.
HEPATOLOGY RESEARCH (2012)
Low serum level of hepatitis B indicates unlikely reactivation core-related antigen of hepatitis after cessation of lamivudine therapy
Akihiro Matsumoto et al.
HEPATOLOGY RESEARCH (2007)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
